ADBiotech Co., Ltd. (KOSDAQ:179530)
South Korea flag South Korea · Delayed Price · Currency is KRW
2,650.00
-25.00 (-0.93%)
At close: Apr 28, 2026

ADBiotech Ratios and Metrics

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2020
Period Ending
Apr '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 2020
Market Capitalization
52,05333,21219,01229,93530,71245,092
Upgrade
Market Cap Growth
176.04%74.69%-36.49%-2.53%-31.89%20.26%
Upgrade
Enterprise Value
57,43932,72727,33039,45935,183-
Upgrade
Last Close Price
2645.002030.002080.003275.003360.009100.00
Upgrade
PE Ratio
----11.39-
Upgrade
PS Ratio
4.042.581.712.862.893.81
Upgrade
PB Ratio
3.392.163.992.381.908.83
Upgrade
P/TBV Ratio
3.402.175.882.661.908.84
Upgrade
P/FCF Ratio
---398.99--
Upgrade
P/OCF Ratio
---95.05--
Upgrade
EV/Sales Ratio
4.452.542.453.773.31-
Upgrade
EV/FCF Ratio
-3.35--525.92--
Upgrade
Debt / Equity Ratio
1.091.092.511.080.792.58
Upgrade
Debt / FCF Ratio
---181.40--
Upgrade
Net Debt / Equity Ratio
0.350.352.160.330.262.04
Upgrade
Net Debt / EBITDA Ratio
-2.10-2.10-3.33-1.15-0.97-11.50
Upgrade
Net Debt / FCF Ratio
-0.31-0.31-2.4055.93-0.44-1.81
Upgrade
Asset Turnover
0.360.360.440.350.410.60
Upgrade
Inventory Turnover
3.323.323.072.782.973.52
Upgrade
Quick Ratio
0.460.460.350.980.890.50
Upgrade
Current Ratio
0.700.700.621.191.200.69
Upgrade
Return on Equity (ROE)
-33.04%-33.04%-103.66%-37.78%25.33%-36.92%
Upgrade
Return on Assets (ROA)
-6.12%-6.12%-10.06%-10.09%-11.98%-4.88%
Upgrade
Return on Capital Employed (ROCE)
-18.70%-18.70%-43.00%-28.40%-25.90%-18.70%
Upgrade
Earnings Yield
-6.35%-9.95%-41.83%-9.57%8.78%-5.91%
Upgrade
FCF Yield
-32.91%-51.58%-22.54%0.25%-30.34%-12.74%
Upgrade
Buyback Yield / Dilution
-31.45%-31.45%0.00%9.33%-31.17%-53.77%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.